NZ approves new Covid drug
Ronapreve is a monoclonal antibody drug that mimics the body's natural defenses for fighting disease, Chris James, group manager at the Health Ministry's medicine regulatory arm Medsafe, said in a statement.
Ronapreve is a monoclonal antibody drug that mimics the body's natural defenses for fighting disease, Chris James, group manager at the Health Ministry's medicine regulatory arm Medsafe, said in a statement.
Patients should be monitored during the infusion and observed for least one hour after the completion of the infusion and 15--30 minutes after the subcutaneous injection.
